Ra Capital Management, L.P.

13F Holdings History for Vaxcyte, Inc. - COMMON STOCK (PCVX)

Symbol: PCVX on Nasdaq
Investment type: Equity / COMMON STOCK
Latest Disclosed Ownership: 13M shares
Security Ownership: 9.9%

Shares, Excluding Options vs Price

Value, Excluding Options

RA Capital Management, L.P. ownership in Vaxcyte, Inc. COMMON STOCK (PCVX)

2025-05-15 - RA Capital Management, L.P. has filed an SCHEDULE 13G/A form with the Securities and Exchange Commission (SEC) disclosing ownership of 13M shares of Vaxcyte, Inc. COMMON STOCK (PCVX). This represents 9.9% percent ownership of the company.

Reporting Name	Ownership %	Change	Value $	Shares owned	Change	Activity %	Price	Form	Report date	Filed at
RA Capital Management, L.P.	9.9%		$364M	13M			$28.04	13G/A	3/31/2025	15 May 2025 16:51:54

Holdings date	Weight	Change	Value $	Shares	Change	Activity %	Price	All Holders
6/30/2025	6.55%	-0.12%	$389M	12M	-223,158	-1.83%	$32.51	Q2 2025
3/31/2025	7.69%	+2.21%	$460M	12.2M	+3,499,959		$37.76	Q1 2025
12/31/2024	9.47%		$711M	8.69M			$81.86	Q4 2024
9/30/2024	11.4%	+0.64%	$993M	8.69M	+485,436	+5.92%	$114.27	Q3 2024
6/30/2024	8.19%		$619M	8.2M			$75.51	Q2 2024
3/31/2024	7.27%	+0.33%	$560M	8.2M	+312,500	+3.96%	$68.31	Q1 2024
12/31/2023	7.74%		$496M	7.89M			$62.80	Q4 2023
9/30/2023	7.92%		$402M	7.89M			$50.98	Q3 2023
6/30/2023	7.44%	+0.57%	$394M	7.89M	+600,000	+8.23%	$49.94	Q2 2023
3/31/2023	6.19%	+1.22%	$273M	7.29M	+1,433,795	+24.5%	$37.48	Q1 2023
12/31/2022	5.7%	+1.24%	$281M	5.86M	+1,276,256	+27.9%	$47.95	Q4 2022
9/30/2022	2.35%		$110M	4.58M			$24.00	Q3 2022
6/30/2022	2.66%		$99.7M	4.58M			$21.76	Q2 2022
3/31/2022	2.41%	+0.18%	$111M	4.58M	+340,739	+8.04%	$24.15	Q1 2022
12/31/2021	1.78%	+0.14%	$101M	4.24M	+343,599	+8.82%	$23.79	Q4 2021
9/30/2021	1.37%	+0.01%	$98.9M	3.9M	+31,057	+0.8%	$25.37	Q3 2021
6/30/2021	1.4%		$87M	3.87M			$22.51	Q2 2021
3/31/2021	1.15%	+0.04%	$76.4M	3.87M	+155,109	+4.18%	$19.75	Q1 2021
12/31/2020	1.38%	-0.58%	$98.6M	3.71M	-1,573,119	-29.8%	$26.57	Q4 2020
9/30/2020	4.77%	-0.19%	$261M	5.28M	-205,363	-3.74%	$49.38	Q3 2020
6/30/2020	3.38%	+3.38%	$174M	5.49M	+5,489,181	NEW	$31.61	Q2 2020

* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.